We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Lennox International
LII
$13B
| $13.1M | 0.02% |
+22,943
| New | +$11.7M |
|
652
Tompkins Financial
TMP
$1.39B
| $13.1M | 0.02% |
138,848
+25,278
| +22% | +$2.18M |
|
653
Workday
WDAY
$44.8B
| $13M | 0.02% |
106,600
-14,200
| -12% | -$1.8M |
|
654
MGM Resorts International
MGM
$10.2B
| $13M | 0.02% |
272,867
+101,667
| +59% | +$4.23M |
|
|
CEPF
655
Cantor Equity Partners IV
CEPF
$593M
| $13M | 0.02% |
1,250,000
| – | – |
|
656
Bunge Global
BG
$23.7B
| $12.9M | 0.02% |
121,000
+200
| +0.2% | +$24.6K |
|
657
Acadia Pharmaceuticals
ACAD
$4.77B
| $12.9M | 0.02% |
510,000
+500,000
| +5,000% | +$11M |
|
658
Leidos
LDOS
$16.1B
| $12.9M | 0.02% |
124,984
+10,884
| +10% | +$1.45M |
|
659
Centene
CNC
$31.6B
| $12.7M | 0.02% |
198,114
+108,075
| +120% | +$5.78M |
|
660
Aflac
AFL
$57.5B
| $12.7M | 0.02% |
108,274
-249,900
| -70% | -$28.8M |
|
661
Super Micro Computer
SMCI
$25.6B
| $12.7M | 0.02% |
431,600
+42,700
| +11% | +$1.36M |
|
662
Broadridge
BR
$19.2B
| $12.6M | 0.02% |
92,100
+9,900
| +12% | +$1.5M |
|
663
Everest Group
EG
$14.1B
| $12.6M | 0.02% |
35,281
-1,000
| -3% | -$342K |
|
664
Deckers Outdoor
DECK
$10.9B
| $12.6M | 0.02% |
126,500
-100
| -0.1% | -$10.5K |
|
|
ADAC
665
American Drive Acquisition Co
ADAC
$290M
| $12.5M | 0.02% |
1,250,000
| – | – |
|
|
LPCV
666
Launchpad Cadenza Acquisition Corp I
LPCV
$288M
| $12.5M | 0.02% |
1,250,000
| – | – |
|
667
Cooper Companies
COO
$12.4B
| $12.5M | 0.02% |
173,860
+149,000
| +599% | +$9.74M |
|
668
Generac Holdings
GNRC
$11B
| $12.4M | 0.02% |
42,458
-9,900
| -19% | -$2.48M |
|
|
NUVL
669
DELISTED
Nuvalent
NUVL
| $12.3M | 0.02% |
100,000
-648,896
| -87% | -$69.8M |
|
670
Las Vegas Sands
LVS
$28.1B
| $12.3M | 0.02% |
265,700
-4,000
| -1% | -$207K |
|
671
Peapack-Gladstone Financial
PGC
$809M
| $12.3M | 0.02% |
259,220
+220,120
| +563% | +$9.31M |
|
672
Gen Digital
GEN
$17.8B
| $12.2M | 0.02% |
491,217
+199,500
| +68% | +$4.46M |
|
673
Arcutis Biotherapeutics
ARQT
$3B
| $12.2M | 0.02% |
466,000
+100,000
| +27% | +$2.33M |
|
|
BLZR
674
Trailblazer Acquisition Corp
BLZR
$351M
| $12.1M | 0.02% |
1,200,000
| – | – |
|
675
Qiagen
QGEN
$8.78B
| $12.1M | 0.02% |
310,000
+25,000
| +9% | +$928K |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.